Compounds > n,n-dipropylcarboxamidotryptamine
Page last updated: 2024-09-04

n,n-dipropylcarboxamidotryptamine and quinoxalines

n,n-dipropylcarboxamidotryptamine has been researched along with quinoxalines in 1 studies

Compound Research Comparison

Studies
(n,n-dipropylcarboxamidotryptamine)		Trials
(n,n-dipropylcarboxamidotryptamine)		Recent Studies (post-2010)
(n,n-dipropylcarboxamidotryptamine)		Studies
(quinoxalines)		Trials
(quinoxalines)		Recent Studies (post-2010) (quinoxalines)
23059,8876253,095

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baudrie, V; Chaouloff, F; Laude, D; Martin, GR1

Other Studies

1 other study(ies) available for n,n-dipropylcarboxamidotryptamine and quinoxalines

ArticleYear
Effects of the 5-HT1 receptor agonists DP-5-CT, CGS 12066B, and RU 24969 on plasma adrenaline and glucose levels in the rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 1990, Volume: 342, Issue:4

    Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Epinephrine; Indoles; Male; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tryptamines

1990